CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
Titel:
CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
Auteur:
Domanska, Urszula M. Timmer-Bosscha, Hetty Nagengast, Wouter B. Oude Munnink, Thijs H. Kruizinga, Roeliene C. Ananias, Hildo J.K. Kliphuis, Nathalie M. Huls, Gerwin De Vries, Elisabeth G.E. de Jong, Igle J. Walenkamp, Annemiek M.E.